Figure 8. High expression of HOXC10 in LUDA tissues represents a worse DMFS. (A–C) Kaplan-Meier survival analysis of DMFS in all stage, stage I-II, and stage III-IV of LUAD patients with low HOXC10 expression versus high HOXC10 expression. (D–F) Kaplan-Meier survival analysis of DMFS in grade I, grade II, and grade III of LUAD patients with low HOXC10 expression versus high HOXC10 expression. (G) Representative IHC images of HOXC10, VEGFA and CD31 expression in LUAD tissues. (H) Staining index of VEGFA in HOXC10-low and HOXC10-high expression LUAD patients. Error bar represents the 10th-90th percentile. (I) The correlation between HOXC10 expression and VEGFA expression in LUAD samples. (J) MVD in HOXC10-low and HOXC10-high expression LUAD patients. (K) The correlation between HOXC10 expression and MVD in LUAD samples.